Skip to main content
NIH Blueprint Logo

Main navigation

  • Funding & Research
    • Funding Opportunities
    • Blueprint Research Initiatives
  • Human Connectome
    • Connectome Programs
    • Connectome Projects
  • Neurotherapeutics
    • Blueprint Neurotherapeutics (BPN) Network
    • Current Drug Development Projects
    • BPN Funding Opportunities
    • How BPN Works: The Virtual Pharma Model
    • BPN Resources
    • BPN Frequently Asked Questions
    • BPN Participating Institutes and Contacts
    • Other NIH Programs for Translational Neuroscience
    • BPN Success Stories
    • BPN News
  • Training
    • ENDURE Undergraduate Education
    • D-SPAN Award (F99/K00)
    • Training in Computational Neuroscience
    • Related NIH-Sponsored Training
    • D-SPAN Awardees
  • Resource & Tools
    • Blueprint Resources & Tools Library
  • About
    • Blueprint Facts
    • Participating NIH Institutes
    • News
    • Events
Toggle Alert Dropdown
COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC: https://www.coronavirus.gov
Get the latest research information from NIH: https://www.nih.gov/coronavirus
NIH staff guidance on coronavirus (NIH Only)

  1. Home
  2. News
SHARE:

News

Filter By:
NIH Default Logo
Tetra Therapeutics Announces Positive Topline Results from Phase 2 Study of BPN14770 in Patients with Fragile X Syndrome
November 02, 2020
NIH Default Logo
W-S startup lands federal grant to support development of medications for cocaine addiction
July 28, 2020
NIH Default Logo
Belite Bio Announces Positive Results from Phase 1 Clinical Trials of LBS-008
July 20, 2020
EicOsis Logo
EicOsis EC5026 Granted Fast Track Designation by FDA for Neuropathic Pain
April 09, 2020
EicOsis Logo
EicOsis Announces FDA Acceptance of IND Application for EC5026, the First Soluble Epoxide Hydrolase Inhibitor to Treat Pain
October 10, 2019
NIH Default Logo
Drug may protect against Alzheimer’s symptoms
September 10, 2019
NIH Default Logo
Tetra Discovery Partners Initiates Phase 2 Clinical Trial of BPN14770 in Patients with Early Alzheimer’s Disease
May 01, 2019
Art for "‘Functional Fingerprint’ May Identify Brains Over a Lifetime"
‘Functional Fingerprint’ May Identify Brains Over a Lifetime
August 16, 2018
NIH Default Logo
New NIH-funded memory drug moves into Phase 1 clinical study
December 30, 2015
Was this page helpful?
Form Approved OMB# 0925-0648 Exp. Date 05/31/2021

About

  • Blueprint Facts
  • Participating NIH Institutes
  • News
  • Events

You Might Also Be Interested In

Image
Blue world map with paths connecting different locations
NIH BRAIN Initiative News
Image
Colorful brain neurons in a bubble
NIH BRAIN Initiative Event Calendar
Image
NIH logo
NIH News & Events

Contact Us

NIH Web Policies & Notices

Archives

Freedom of Information Act (FOIA)

Tools

Download Adobe Plug-In

Releated

National Institutes of Health
Department of Health & Human Services
USA.gov

Partners

NCATS
NCCIH
NEI
NIA
NIAA
NIBIB
NICHD
NIDA
NIDCR
NIEHS
NIMH
NINDS
NINR
OBSSR
NIH Blueprint Logo NIH Blueprint for Neuroscience Research